PXD034882
PXD034882 is an original dataset announced via ProteomeXchange.
Dataset Summary
Title | Tandem Mass Tag-Based Quantitative Proteomic Profiling Identifies Novel Serum Biomarkers of Drug-Induced Liver Injury in Humans |
Description | Diagnosis of drug-induced liver injury (DILI) and its distinction from other liver diseases are significant challenges in drug development and clinical practice. In this study we identify, confirm, and replicate the biomarker performance characteristics of candidate proteins in a cohort of patients with DILI at onset (DO; n = 133) and follow-up (DF; n = 120), acute non-DILI at onset (NDO; n = 63) and follow-up (NDF; n = 42), and healthy volunteers (HV; n = 104). Area under the receiver operating characteristic curve (AUC) for cytoplasmic aconitate hydratase; argininosuccinate synthase; carbamoylphosphate synthase, fumarylacetoacetase; fructose-1,6-bisphosphatase 1 (FBP1) across cohorts achieves near complete separation (range: 0.94 - 0.99) of DO and HV. In addition, we show that FBP1 alone or in combination with glutathione S-transferase A1 and leukocyte cell derived chemotaxin 2 could potentially assist in clinicla diagnosis by distinguishing NDO from DO (AUC range: 0.65 – 0.78), but further technical and clinical validation of these candidate biomarkers is needed. |
HostingRepository | PanoramaPublic |
AnnounceDate | 2024-01-04 |
AnnouncementXML | Submission_2024-01-04_11:58:18.005.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Joel Federspiel |
SpeciesList | scientific name: Homo sapiens; NCBI TaxID: 9606; |
ModificationList | Label:13C(6)15N(2); Label:13C(6)15N(4) |
Instrument | Orbitrap Exploris 480 |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
---|---|---|---|
0 | 2022-06-25 23:13:10 | ID requested | |
1 | 2023-01-26 11:28:31 | announced | |
⏵ 2 | 2024-01-04 11:58:18 | announced | : Added PubMed Id |
Publication List
Ravindra KC, Vaidya VS, Wang Z, Federspiel JD, Virgen-Slane R, Everley RA, Grove JI, Stephens C, Ocana MF, Robles-D, í, az M, Isabel Lucena M, Andrade RJ, Atallah E, Gerbes AL, Weber S, Cortez-Pinto H, Fowell AJ, Hussaini H, Bjornsson ES, Patel J, Stirnimann G, Verma S, Elsharkawy AM, Griffiths WJH, Hyde C, Dear JW, Aithal GP, Ramaiah SK, Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans. Nat Commun, 14(1):1215(2023) [pubmed] |
Keyword List
submitter keyword: DILI, Biomarker, Liver Disease |
Contact List
Mireia Fernandez Ocana | |
---|---|
contact affiliation | Pfizer Inc. |
contact email | mireia.fernandezocana@pfizer.com |
lab head | |
Joel Federspiel | |
contact affiliation | Pfizer, Inc. |
contact email | joel.federspiel@pfizer.com |
dataset submitter |
Full Dataset Link List
Panorama Public dataset URI |